Format

Send to

Choose Destination
See comment in PubMed Commons below
Molecules. 2014 Mar 21;19(3):3539-51. doi: 10.3390/molecules19033539.

Design, synthesis and SAR study of novel trisubstituted pyrimidine amide derivatives as CCR4 antagonists.

Author information

1
School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China. xulibao2003@163.com.
2
Department of Immunology, School of Basic Medical Sciences, Key Laboratory of Medical Immunology, Ministry of Health, Peking University Health Science Center, Beijing 100191, China. byzhangyang08@163.com.
3
Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China. wenjiedai.2009@163.com.
4
Department of Immunology, School of Basic Medical Sciences, Key Laboratory of Medical Immunology, Ministry of Health, Peking University Health Science Center, Beijing 100191, China. yw@bjmu.edu.cn.
5
Laboratory of Computer-Aided Drug Design & Discovery, Beijing Institute of Pharmacology & Toxicology, Beijing 100850, China. jiangdan@263.net.cn.
6
Laboratory of Computer-Aided Drug Design & Discovery, Beijing Institute of Pharmacology & Toxicology, Beijing 100850, China. wangll63@126.com.
7
Laboratory of Computer-Aided Drug Design & Discovery, Beijing Institute of Pharmacology & Toxicology, Beijing 100850, China. xiaojunhai@139.com.
8
School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China. xiaohongyang88@126.com.
9
School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China. lis@bmi.ac.cn.

Abstract

The design, synthesis and structure-activity relationship studies of some novel trisubstituted pyrimidine amide derivatives prepared as CCR4 antagonists are described. The activities of these compounds were evaluated by the CCR4-MDC chemotaxis inhibition assay. Compound 1, which we have previously reported as a potent antagonist of CCR4, was employed as the positive control. The results indicated that most of the synthesized compounds exhibited some chemotaxis inhibition activity against CCR4. Of these new compounds, compounds 6c, 12a and 12b, with IC₅₀ values of 0.064, 0.077 and 0.069 μM, respectively, showed higher or similar activity compared with compound 1 (IC₅₀ of 0.078 μM). These compounds provide a basis for further structural modifications. The systematic structure-activity relationship of these trisubstituted pyrimidine amide derivatives was discussed based on the obtained experimental data. The results from the SAR study may be useful for identifying more potent CCR4 antagonists.

PMID:
24662072
DOI:
10.3390/molecules19033539
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Multidisciplinary Digital Publishing Institute (MDPI)
    Loading ...
    Support Center